Earlier quoted context omitted.
No, it won't. Speaking as someone who is currently spending his days sourcing medical equipment for his medical center: the cheapest US-based face shield costs nearly 3x what the average face shield in China does (the most expensive US face shield is >10x). Even with shipping hiccoughs and the desire to buy American, I can't justify purchasing 1/3 the personal protective equipment.
In the current situation they probably don't have a lot of incentive to lower prices. But the question is: how much premium would you be willing to pay for a local supplier? If the american company was "only" 50% more expensive, would it work out after the pandemic?
I mean, as a personal consumer, yes - I'd pay a premium on my own products to buy American. I do, in fact, do that when it's an option.
As an organizational representative, though, that's iffier. Healthcare reimbursement is pretty heavily regulated (most of the wild price fluctuation you see has to do with numbers used for public-facing negotiations, not the contracted rates we actually ever get paid.) The only way we get by is by minimizing costs; we can't really increase revenue effectively, except by increasing volume of services. As it is, operating margins in hospitals tend to run at about 2% - it's razor, razor thin. Upping expenses 50% on "critical" items (which for us is, you know, a huge proportion of our stuff) would put us out of business.
It's not something we can do unilaterally. Either it has be funded through an increase in funding earmarked for that, or something equivalent.